Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederic Pouliot

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
JCO Global Oncology|November 22, 2023
Trends of Utilization of Systemic Therapies for Metastatic Renal Cell Carcinoma in the Canadian Health Care SystemLuisa M Cardenas, Sunita Ghosh, Antonio Finelli, et al.
Cancer Research|March 5, 2015
CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapyJemima Escamilla, Shiruyeh Schokrpur, Connie Liu, et al.
The Journal of Urology|December 21, 2020
Hypothermia During Partial Nephrectomy for Patients with Renal Tumors: A Randomized Controlled TrialRodney H Breau, Dean A Fergusson, Greg Knoll, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 28, 2020
Real-world management of advanced prostate cancer: A description of management practices of community-based physicians and prostate cancer specialistsSebastien J Hotte, Antonio Finelli, Kim N Chi, et al.
Clinical Genitourinary Cancer|May 1, 2026
Bone Metastases and Use of Bone Protective Agents for Metastatic Clear Cell Renal Cell Carcinoma: A Contemporary National Real-World AnalysisBraden Millan, Sunita Ghosh, Naveen S Basappa, et al.
The Journal of Urology|August 22, 2025
Incidence of local treatment and metastasis during active surveillance for patients with a small renal mass in a national multicenter prospective cohortLuke T Lavallée, Antonio Finelli, Simon Tanguay, et al.
Clinical Genitourinary Cancer|February 9, 2022
Establishing metastatic prostate cancer quality indicators using a modified Delphi approachJia Zheng, Fanny Sampurno, Daniel J George, et al.
Current Oncology (Toronto, Ont.)|March 27, 2026
Outcomes and Predictors of Recurrence and Survival in Surgically Resected Localized Chromophobe Renal Cell Carcinoma: Results from the Canadian Kidney Cancer Information System (CKCis)Erica Arenovich, Rodney Breau, Ricardo Rendon, et al.
Urologic Oncology|June 9, 2026
Comparison of partial nephrectomy to radical nephrectomy for non-metastatic cT2 renal tumors: Results from a Canadian Multi-Institutional CollaborativeRahul K Bansal, Raees Cassim, Ranjeeta Mallick, et al.
Journal of Geriatric Oncology|February 15, 2026
Real-world management and clinical outcomes of first line treatment of advanced renal cell carcinoma in older patients in CanadaLauren Curry, Sunita Ghosh, Erica Arenovich, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
JCO Global Oncology|November 22, 2023
Trends of Utilization of Systemic Therapies for Metastatic Renal Cell Carcinoma in the Canadian Health Care SystemLuisa M Cardenas, Sunita Ghosh, Antonio Finelli, et al.
Cancer Research|March 5, 2015
CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapyJemima Escamilla, Shiruyeh Schokrpur, Connie Liu, et al.
The Journal of Urology|December 21, 2020
Hypothermia During Partial Nephrectomy for Patients with Renal Tumors: A Randomized Controlled TrialRodney H Breau, Dean A Fergusson, Greg Knoll, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 28, 2020
Real-world management of advanced prostate cancer: A description of management practices of community-based physicians and prostate cancer specialistsSebastien J Hotte, Antonio Finelli, Kim N Chi, et al.
Clinical Genitourinary Cancer|May 1, 2026
Bone Metastases and Use of Bone Protective Agents for Metastatic Clear Cell Renal Cell Carcinoma: A Contemporary National Real-World AnalysisBraden Millan, Sunita Ghosh, Naveen S Basappa, et al.
The Journal of Urology|August 22, 2025
Incidence of local treatment and metastasis during active surveillance for patients with a small renal mass in a national multicenter prospective cohortLuke T Lavallée, Antonio Finelli, Simon Tanguay, et al.
Clinical Genitourinary Cancer|February 9, 2022
Establishing metastatic prostate cancer quality indicators using a modified Delphi approachJia Zheng, Fanny Sampurno, Daniel J George, et al.
Current Oncology (Toronto, Ont.)|March 27, 2026
Outcomes and Predictors of Recurrence and Survival in Surgically Resected Localized Chromophobe Renal Cell Carcinoma: Results from the Canadian Kidney Cancer Information System (CKCis)Erica Arenovich, Rodney Breau, Ricardo Rendon, et al.
Urologic Oncology|June 9, 2026
Comparison of partial nephrectomy to radical nephrectomy for non-metastatic cT2 renal tumors: Results from a Canadian Multi-Institutional CollaborativeRahul K Bansal, Raees Cassim, Ranjeeta Mallick, et al.
Journal of Geriatric Oncology|February 15, 2026
Real-world management and clinical outcomes of first line treatment of advanced renal cell carcinoma in older patients in CanadaLauren Curry, Sunita Ghosh, Erica Arenovich, et al.
Pageof 4